Fig. 1From: Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapyGYN SABR of recurrent nodal disease from endometrial cancer Nodal recurrence is bordering previous treatment field. Patient had previous FIGO IB, Grade 2 endometrioid adenocarcinoma with multifocal LVSI (no nodes removed) treated with pelvic radiation 4 years prior to SABR treatment. Prescription dose 35 Gy in 5 fractionsBack to article page